Lipidomics analyses of ATTIRE trial patients’ plasma at day 1 demonstrates that reduced cholesterol esterification predicts development of hospital acquired infection

Fuller, H, Tittanegro, T, Maini, A et al. (4 more authors) (2022) Lipidomics analyses of ATTIRE trial patients’ plasma at day 1 demonstrates that reduced cholesterol esterification predicts development of hospital acquired infection. In: Journal of Hepatology. The International Liver Congress™ 2022, 22-26 Jun 2022, London, United Kingdom. Elsevier , S104-S104.

Metadata

Item Type:	Proceedings Paper
Authors/Creators:	Fuller, H Tittanegro, T Maini, A China, L Thorne, J Moore, JB https://orcid.org/0000-0003-4750-1550 O'Brien, A
Dates:	Published: July 2022 Published (online): 4 July 2022
Institution:	The University of Leeds
Academic Units:	The University of Leeds > Faculty of Environment (Leeds) > School of Food Science and Nutrition (Leeds) > FSN Nutrition and Public Health (Leeds)
Depositing User:	Symplectic Publications
Date Deposited:	10 Oct 2022 10:31
Last Modified:	10 Oct 2022 10:31
Status:	Published
Publisher:	Elsevier
Identification Number:	10.1016/S0168-8278(22)00597-9
Related URLs:	Author
Open Archives Initiative ID (OAI ID):	oai:eprints.whiterose.ac.uk:191866

CORE (COnnecting REpositories)

Lipidomics analyses of ATTIRE trial patients’ plasma at day 1 demonstrates that reduced cholesterol esterification predicts development of hospital acquired infection

Metadata

Download not available

Export

Statistics